Durable Efficacy of Certolizumab Pegol Dosed at 400 mg Every Two Weeks Over 128 Weeks in Patients with Plaque Psoriasis Enrolled in Three Phase 3 Trials (CIMPASI-1, CIMPASI-2, and CIMPACT). J of Skin [Internet]. 2020 Oct. 27 [cited 2025 Apr. 19];4(6):s81. Available from: https://skin.dermsquared.com/skin/article/view/1114